Supplementary Therapeutic Possibilities to Alleviate Myocardial Damage Due to Microvascular Dysfunction in Coronavirus Disease 2019 (COVID-19)
Crossref DOI link: https://doi.org/10.1007/s40119-021-00216-8
Published Online: 2021-04-02
Published Print: 2021-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Medvegy, Mihály
Simonyi, Gábor
Funding for this research was provided by:
Servier
Text and Data Mining valid from 2021-04-02
Version of Record valid from 2021-04-02
Article History
Received: 17 February 2021
First Online: 2 April 2021